XML 73 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2015
Fair Value Disclosures [Abstract]  
Financial Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table classifies the Company’s financial assets and liabilities measured at fair value on a recurring basis at September 30, 2015 and December 31, 2014, respectively into the fair value hierarchy:

 

 

Balance at September 30, 2015

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Asset included in:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market securities

 

$

2,573,882

 

 

$

 

 

$

 

 

$

2,573,882

 

 

Investments at fair value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government obligations

 

$

3,308,573

 

 

$

 

 

$

 

 

$

3,308,573

 

 

U.S. government agency obligations

 

$

 

 

$

14,715,616

 

 

$

 

 

$

14,715,616

 

 

Corporate debt securities

 

$

 

 

$

18,454,522

 

 

$

 

 

$

18,454,522

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2014

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Asset included in:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market securities

 

$

3,608,890

 

 

$

 

 

 

 

 

 

$

3,608,890

 

 

Liabilities included in:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Growth Term Loan warrants

 

$

 

 

$

 

 

$

301,508

 

 

$

301,508

 

 

Convertible Preferred Stock warrants

 

$

 

 

$

 

 

$

429,035

 

 

$

429,035

 

 

 

Summary of Fair Value Assessment of Warrant Liability Inputs using Black Sholes Option Pricing Model

The December 31, 2014 fair value assessments used the Black-Sholes option pricing model using the following assumptions:

 

 

 

December 31, 2014

 

Fair value of Series B/C/D Stock and Series E Stock

   shares on grant date or measurement date

 

$0.14 - $0.22

 

Exercise price

 

$0.01 - $0.346

 

Expected risk-free interest rate

 

 

1.20%

 

Expected volatility

 

 

70%

 

Expected term

 

4.1 years

 

Expected dividend yield

 

0 - 8%

 

 

Reconciliation of Beginning and Ending Liabilities Measured at Fair Value on Recurring Basis

A reconciliation of the beginning and ending liabilities measured at fair value and classified as Level 3 inputs for the nine months ended September 30, 2015 and September 30, 2014 are as follows:

 

 

 

September 30,

 

 

 

2015

 

 

2014

 

Beginning balance

 

$

730,543

 

 

$

44,120

 

Issuance of Series E Convertible Preferred Stock Warrants

 

 

 

 

 

2,191,507

 

Exercise of Series E Convertible Preferred Stock Warrants

 

 

(4,116

)

 

 

(1,890,000

)

Exercise of Series D Convertible Preferred Stock Warrants

 

 

(91,798

)

 

 

 

Reclassification of Series C-2 Convertible Preferred Stock

   Warrants to Common Stock Warrants

 

 

(555

)

 

 

 

Reclassification of Growth Term Loan Warrants to

   Common Warrants

 

 

(229,550

)

 

 

 

Issuance of Convertible Note Warrants

 

 

741,828

 

 

 

 

Reclassification of Convertible Note Warrants to

   Common Stock Warrants

 

 

(1,386,035

)

 

 

 

Change in Convertible Preferred Stock warrant valuation

 

 

239,683

 

 

 

56,322

 

Ending balance

 

$

 

 

$

401,949